Epithalon (Epitalon) has demonstrated telomere elongation in cell culture and aged animal models, primarily through activation of telomerase. Human evidence is limited to a small number of studies from a single Russian research group, which limits the reliability of current conclusions.
How does Epithalon activate telomerase?
Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) originally isolated from the pineal gland. In vitro studies show it stimulates telomerase expression in human somatic cells, which normally lack active telomerase. The proposed pathway involves interaction with chromatin structure and gene expression regulation, though the precise molecular mechanism remains incompletely characterised.
What is the replication problem with Epithalon research?
The majority of published Epithalon studies originate from the St. Petersburg Institute of Bioregulation and Gerontology, primarily from one research group. Independent replication outside this institution is almost entirely absent. This is the central evidentiary weakness — not the findings themselves, but their single-source origin. Until independent groups replicate the core telomere findings, the evidence base cannot be considered robust.